Open AccessOutcomes of Male Patients with Alport Syndrome Undergoing Renal Replacement Therapy
Author(s) -
Johanna Temme,
Anneke Kramer,
Kitty J. Jager,
Katharina Lange,
Frederik Peters,
GerhardAnton Müller,
Reinhard Kramar,
James Heaf,
Patrik Finne,
Runólfur Pálsson,
Anna Varberg Reisæter,
Andries J. Hoitsma,
Wendy Metcalfe,
Maurizio Postorino,
Óscar Zurriaga,
Julio Pascual Santos,
Pietro Ravani,
F. Jarraya,
Enrico Verrina,
Friedo W. Dekker,
Oliver Groß
Publication year - 2012
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02190312
Subject(s) - medicine , alport syndrome , renal replacement therapy , urology , glomerulonephritis , kidney
Patients with the hereditary disease Alport syndrome commonly require renal replacement therapy (RRT) in the second or third decade of life. This study compared age at onset of RRT, renal allograft, and patient survival in men with Alport syndrome receiving various forms of RRT (peritoneal dialysis, hemodialysis, or transplantation) with those of men with other renal diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom